Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Msphere|November 2, 2022
Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary InfectionMohammad M Sajadi, Amber Myers, James Logue, et al.Mbio|November 17, 2011
Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infectionXinxia Peng, Lisa Gralinski, Martin T Ferris, et al.Life Science Alliance|December 13, 2019
Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domainCamilla To Benfield, Farrell MacKenzie, Markus Ritzefeld, et al.Journal of Virology|November 6, 2009
The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell deathEric C Freundt, Li Yu, Cynthia S Goldsmith, et al.Antimicrobial Agents and Chemotherapy|May 21, 2014
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infectionJulie Dyall, Christopher M Coleman, Brit J Hart, et al.Mbio|October 28, 2010
Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signalingXinxia Peng, Lisa Gralinski, Christopher D Armour, et al.Msystems|November 9, 2016
A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA VirusesLindsey A Moser, Lisbeth Ramirez-Carvajal, Vinita Puri, et al.Nature Communications|October 6, 2023
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seqSara Sunshine, Andreas S Puschnik, Joseph M Replogle, et al.The Lancet. Infectious Diseases|August 13, 2022
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trialRaburn M Mallory, Neil Formica, Susan Pfeiffer, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infectionKristen E Pascal, Christopher M Coleman, Alejandro O Mujica, et al.Pageof 12